AITIA
Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins of disease in oncology, neurodegenerative disorders, and immunology. Gemini Digital Twins are being used today to discover novel therapies and accelerate R&D in multiple myel... oma, prostate cancer, Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease, with several more in development. Aitia’s partners include seven of the top ten pharmaceutical companies, leading academic research and medical centers, medical societies, leading multi-omic data companies, and patient advocacy groups globally.
AITIA
Industry:
Big Data Bioinformatics Genetics
Founded:
2000-01-01
Address:
Somerville, Massachusetts, United States
Country:
United States
Website Url:
http://www.aitiabio.com
Total Employee:
11+
Status:
Active
Contact:
+1 617 374 2300
Total Funding:
77.26 M USD
Technology used in webpage:
Domain Not Resolving SPF HSTS IPv6 Cloudflare Hosting Microsoft Exchange Online Google Office 365 Mail Google Cloud Cloudflare CDN
Similar Organizations
4D Molecular Therapeutics
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
dbt Labs
Dbt Labs develops an analytics engineering tool that prepares raw data in the warehouse for analysis.
Encoded Therapeutics
Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.
Granify
Granify employs big data and machine learning technologies to enable online retailers to enhance their sales via a SaaS-based solution.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Sidecar
Sidecar is an e-commerce marketing company that builds the technology retailers need to optimize cross-channel online shopping campaigns.
Voltaiq
Voltaiq is the industry’s first Enterprise Battery Intelligence™ (EBI) software platform helping optimize battery performance & reliability
Current Advisors List
Advisor
Board_member
2017-04-01
Advisor
Advisor
Board_member
2013-12-01
Advisor
Advisor
Advisor
Current Employees Featured
Colin Hill CEO @ Aitia
CEO
2010-04-01
Bruce Church Chief Mathematics Officer @ Aitia
Chief Mathematics Officer
2013-01-01
John Levinson Advisor to CEO @ Aitia
Advisor to CEO
2007-01-01
Jean-Michel Gries President & Chief Operating Officer @ Aitia
President & Chief Operating Officer
2023-01-01
Joseph F. Donahue Chief Business Officer @ Aitia
Chief Business Officer
2022-03-01
David Gascoigne Chief Operating Officer @ Aitia
Chief Operating Officer
2018-01-01
Founder
Investors List
Celgene
Celgene investment in Series D - Aitia
Cigna Ventures
Cigna Ventures investment in Series D - Aitia
Amgen Ventures
Amgen Ventures investment in Series D - Aitia
Gary Loveman
Gary Loveman investment in Series D - Aitia
Echo Health Ventures
Echo Health Ventures investment in Series D - Aitia
Alexandria Venture Investments
Alexandria Venture Investments investment in Series D - Aitia
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Venture Round - Aitia
Amgen Ventures
Amgen Ventures investment in Venture Round - Aitia
Alexandria Real Estate Equities
Alexandria Real Estate Equities investment in Series C - Aitia
Gi Global Health Fund LP
Gi Global Health Fund LP investment in Series C - Aitia
Key Employee Changes
Official Site Inspections
http://www.aitiabio.com Semrush global rank: 7.49 M Semrush visits lastest month: 757
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aitia"
Leading Experts in AI-Enabled Drug Discovery - Aitia Bio
Our mission is to build the leading AI-enabled biotech company, to reveal hidden biological mechanisms of disease and discover breakthrough drugs.By harnessing the power of causal …See details»
Aitia - LinkedIn
Aitia is the leader in the development and application of Causal AI and Digital Twins to discover the next generation of therapies for neurodegenerative …See details»
Aitia - Crunchbase Company Profile & Funding
Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs. By leveraging the convergence of multi-omic patient data, high …See details»
Aitia 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Aitia. Use the PitchBook Platform to explore the full profile.See details»
Aitia - Overview, News & Similar companies | ZoomInfo.com
Aitia contact info: Phone number: (617) 374-2300 Website: www.aitiabio.com What does Aitia do? Aitia is the leader in the application of Causal AI and Digital Twins to discover the next …See details»
Aitia Company Profile - Office Locations, Competitors, Revenue
Aitia has 5 employees at their 1 location and $76.06 m in total funding,. See insights on Aitia including office locations, competitors, revenue, financials, executives, subsidiaries and more …See details»
Aitia (Formerly GNS Healthcare) | F6S
Aitiabio.com About Aitia (Formerly GNS Healthcare) Aitia is the leader in the development and application of Causal AI and Digital Twins to discover the next generation of breakthrough …See details»
Aitia - 2025 Company Profile, Funding & Competitors - Tracxn
May 11, 2025 Aitia - Provider of contract based drugs discovery services. Raised a total funding of $63.8M over 9 rounds from 18 investors. Valued at $5.94M. Founded by Colin Hill in the …See details»
Companies - Kensa Group
561 Windsor St, A200 Somerville, MA 02143 Phone: (617) 374-2300 Fax: (617) 494-0114 www.aitiabio.comSee details»
Discovering Next Generation Drugs with Gemini Digital Twins
Our AI approaches are poised to disrupt new areas of drug discovery, unlocking the potential to discover the next generation of breakthrough drugs by creating Gemini Digital Twins of human …See details»
GNS Rebrands as Aitia to Focus on AI-Enabled Drug Discovery
Somerville, MA, January 9, 2023: GNS, the leader in the application of causal AI and “Digital Twins” to discover and develop new drugs, announced today its rebranding as Aitia …See details»
Orion and Aitia Enter AI-Driven Drug Discovery and Drug …
Sep 25, 2024 Aitia to receive payments totalling to more than $10 million per target plus royalties. Somerville, MA, USA and Espoo, Finland, September 25, 2024 – Orion Corporation …See details»
GNS Healthcare Blog
What does the future of pharma look like through the eyes of a technologist’s background? We were fortunate enough to find out at last month at our 2 nd annual GNS Forum. Shahram …See details»
Aitia and UCB Announce Strategic Drug Discovery Collaboration in ...
Zena Sfeir, Vice President of Marketing (Aitia), +1.617.374.2300 or email zsfeir@aitiabio.com About UCB UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company …See details»
Pancreatic Cancer: Aitia and Servier will collaborate
Somerville, MA, May 17, 2023: Aitia, the leader in the development and application of Causal AI and “Digital Twins” to discover and develop new drugs, today announced a collaboration with …See details»
Aitia Enters into Multi-Year AI-Driven Drug Discovery and Drug ...
May 17, 2023 According to the World Health Organization, pancreatic cancer is estimated to be the seventh most common cause of cancer related deaths worldwide, accounting for more …See details»
Aitia Offers Boston-based Drug Discovery Careers
Make an impact with a career in drug discovery at Aitia, a Boston-based biotech company.See details»
Aitia Expand Collaboration with Servier to Discover and Develop …
Oct 30, 2024 icaffry@aitiabio.com +1-617-374-2300. Ryan Flinn In Like Flinn Communications ryan@inlikeflinncommunications.com +1 510-207-7616. BACK TO NEWS; LATEST FROM …See details»
Aitia and Pancreatic Cancer Action Network Partner to Transform …
Sep 27, 2023 LOS ANGELES and SOMERVILLE, MA, Sept 27, 2023: Aitia, the leader in the development and application of Causal AI and Digital Twins to discover and develop new …See details»
Using AI to Discover Progression Biomarkers and Subpopulations …
During this webinar, GNS is joined by Amrita Mohan of CHDI, a biomedical research organization devoted to developing drugs that will slow the progression of Huntington’s disease and provide …See details»